EPCS 2.0 Act

Bill 118 s 2666, also known as the EPCS 2.0 Act, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to enhance the security and efficiency of electronic prescribing of controlled substances (EPCS) in the United States.

The EPCS 2.0 Act aims to address the growing concerns surrounding the misuse and abuse of controlled substances by requiring healthcare providers to use electronic prescribing systems that meet certain security standards. This will help to prevent fraudulent prescriptions and ensure that patients receive the correct medications in a timely manner.

Additionally, the bill includes provisions to improve interoperability between different electronic health record systems, making it easier for healthcare providers to access and share patient information securely. This will help to streamline the prescribing process and reduce the risk of errors or delays in patient care. Overall, the EPCS 2.0 Act is designed to modernize and strengthen the electronic prescribing system for controlled substances in the United States, with the ultimate goal of improving patient safety and reducing the potential for abuse and misuse of these medications.